Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maple Biosciences is a multi-faceted biotechnology company and contract development and manufacturing organization (CDMO) based in Hayward, California. The company provides a range of services including cell line development, protein expression, and advanced genomic analysis through its CLIA-certified and CAP-accredited laboratory. Maple Biosciences specializes in high-throughput next-generation sequencing (NGS) and bioinformatics to support precision medicine, biomarker discovery, and clinical trial enrichment. Additionally, their CDMO division offers expertise in developing high-yield CHO cell lines and manufacturing biologics for therapeutic research. By integrating genomic insights with bioprocessing capabilities, Maple Biosciences supports the entire drug development lifecycle from early-stage discovery to clinical diagnostics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maple Biosciences.